Kyogoku unyu shoji
9073
BlueMeme
4069
Estore
4304
Visumo
303A
D. Western Therapeutics Institute
4576
(Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -7.37%120.63M | 48.72%232.36M | 6.06%609.42M | 39.50%165.01M | 11.98%157.94M | 7.64%130.23M | -19.57%156.25M | -43.37%574.59M | 0.77%118.28M | -35.93%141.05M |
Cost of revenue | -17.05%97.27M | 11.51%127.61M | 17.55%478.12M | 42.25%133.74M | 9.16%112.67M | 16.95%117.26M | 4.78%114.44M | -53.15%406.72M | -20.27%94.02M | -43.00%103.22M |
Gross profit | 80.19%23.36M | 150.54%104.75M | -21.78%131.31M | 28.85%31.26M | 19.68%45.27M | -37.43%12.97M | -50.84%41.81M | 14.64%167.87M | 4,543.59%24.26M | -3.19%37.83M |
Operating expense | 79.80%245.74M | 31.80%195.63M | 4.76%608.34M | 8.92%161.24M | 8.95%161.99M | -23.40%136.68M | 40.64%148.43M | -24.75%580.69M | -23.24%148.04M | 2.83%148.69M |
Operating profit | -79.76%-222.38M | 14.76%-90.88M | -15.55%-477.03M | -5.01%-129.98M | -5.29%-116.73M | 21.55%-123.71M | -420.38%-106.62M | 33.98%-412.82M | 36.00%-123.78M | -5.06%-110.86M |
Net non-operating interest income (expenses) | 100.77%57K | 81.20%-2.8M | 34.82%-23.67M | 101.82%303K | 85.04%-1.65M | -13.74%-7.41M | -601.41%-14.91M | -176.81%-36.31M | -739.89%-16.66M | -94.15%-11.02M |
Non-operating interest income | 3,488.57%7.54M | --730K | --816K | --303K | --303K | --210K | --0 | --0 | --0 | --0 |
Non-operating interest expense | 99.55%7.48M | -76.30%3.53M | -44.95%19.99M | --0 | -87.94%1.33M | -42.47%3.75M | 601.41%14.91M | 261.49%36.31M | 739.89%16.66M | 244.25%11.02M |
Total other finance cost | ---- | ---- | --4.5M | --0 | --623K | ---- | ---- | ---- | ---- | ---- |
Net investment income | 8.15%4.82M | 1,045.20%3.74M | -75.28%2.59M | 34.27%-3.26M | -52.95%1.79M | -64.46%4.45M | 55.75%-396K | 309.45%10.49M | -25.41%-4.96M | 616.73%3.81M |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
Income from associates and other participating interests | ||||||||||
Special income (charges) | -384.63%-1.1B | -6.04M | -2,096.58%-2.34M | 215.84%2.31M | 7,478.76%222.29M | -7,564,500.00%-226.93M | 0 | 100.01%117K | 98.05%-2M | 101.17%2.93M |
Less:Other special charges | --687.38M | --6.04M | 83.89%-2.31M | ---- | ---- | ---- | ---- | -126.90%-14.34M | -111.94%-6.52M | -979.42%-7.82M |
Less:Write off | ---- | ---- | -67.33%4.65M | --0 | -4,650.36%-222.29M | ---- | ---- | -98.16%14.23M | -87.84%8.52M | -98.05%4.89M |
Other non-operating income (expenses) | 111.25%409K | 129.32%563K | -115.05%-5.2M | -98.90%289K | 102.59%71K | -138.99%-3.64M | -209.71%-1.92M | 481.76%34.51M | 820.39%26.18M | -343.77%-2.74M |
Income before tax | -283.76%-1.37B | 22.96%-95.41M | -25.15%-505.64M | -7.53%-130.33M | 189.74%105.78M | -150.94%-357.24M | -448.34%-123.85M | 71.87%-404.02M | 59.46%-121.2M | 67.30%-117.87M |
Income tax | -27.62%841K | 1.60%1.14M | 0.11%4.59M | -61.61%1.16M | 118.97%1.14M | 121.76%1.16M | 115.52%1.13M | 8.76%4.58M | 105.10%3.01M | -99.16%522K |
Net income | -282.75%-1.37B | 22.74%-96.56M | -24.87%-510.22M | -5.85%-131.49M | 188.38%104.63M | -150.84%-358.4M | -440.80%-124.97M | 71.63%-408.6M | 48.22%-124.22M | 71.98%-118.4M |
Net income continuous operations | -282.75%-1.37B | 22.74%-96.56M | -24.87%-510.22M | -5.85%-131.49M | 188.38%104.63M | -150.84%-358.4M | -440.82%-124.97M | 71.63%-408.6M | 48.22%-124.22M | 71.98%-118.4M |
Noncontrolling interests | ||||||||||
Net income attributable to the company | -282.75%-1.37B | 22.74%-96.56M | -24.87%-510.22M | -5.85%-131.49M | 188.38%104.63M | -150.84%-358.4M | -440.80%-124.97M | 71.63%-408.6M | 48.22%-124.22M | 71.98%-118.4M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | -282.75%-1.37B | 22.74%-96.56M | -24.87%-510.22M | -5.85%-131.49M | 188.38%104.63M | -150.84%-358.4M | -440.80%-124.97M | 71.63%-408.6M | 48.22%-124.22M | 71.98%-118.4M |
Gross dividend payment | ||||||||||
Basic earnings per share | -163.02%-16.36 | 53.41%-1.23 | 18.57%-7.98 | 41.75%-1.73 | 191.90%2.61 | -81.34%-6.22 | -371.43%-2.64 | 78.79%-9.8 | 37.08%-2.97 | 80.13%-2.84 |
Diluted earnings per share | -163.02%-16.36 | 53.41%-1.23 | 18.57%-7.98 | 40.23%-1.7778 | 149.81%1.4147 | -81.34%-6.22 | -371.43%-2.64 | 78.79%-9.8 | 49.52%-2.9746 | 80.13%-2.84 |
Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |